Thierry co-founded Kurma Partners in 2009 after leaving AGF Private Equity. He has 25 years of experience in Life Sciences, both in Venture and in Industry, and is a Pharmacist + PhD and MBA. Thierry started his career in 1992 as R&D Project Manager for Laboratoires Fournier in Japan. After his graduation at INSEAD in 1996, he joined Flamel Technologies, just after its successful listing on Nasdaq, and managed the development-stage portfolio of the company. In 1998, he moved to investments, first at Caisse des Dépots (CDC), then at AGF Private Equity (Allianz Group), where he supervised the healthcare investment team. Thierry has led investments in more than 25 companies like Actelion, Arpida, Targacept, Adocia, Auris or Erytech. He is currently a Board Member of Meiogenix (France), Pathoquest (France), Blink Biomedical (France), Asarina Pharma (Denmark), Minoryx (Spain) and Horama (France).